MSP Recovery, Inc. (MSPRW) 주식 분석

회사 개요

MSP Recovery, Inc., which operates under the trade name LifeWallet, functions as a healthcare recovery and data analytics firm serving markets in the United States and Puerto Rico. The entity specializes in claims recovery services, providing assistance to related parties and third parties in the pursuit of recovering claims. Specific sector and industry classifications for this company are not currently listed in available public records, which suggests the firm operates within a niche segment of the broader financial or healthcare services landscape. The company's scale is defined by a market capitalization that is not publicly disclosed, an annual trailing twelve-month revenue of $9.81M, and a workforce comprising 78 employees. The combination of a sub-$10M revenue stream and a small employee base indicates that the company operates as a micro-cap entity with a very limited operational footprint relative to larger industry peers. The absence of a market cap figure alongside the stated revenue implies that the company may not yet be valued in traditional public market terms or that its valuation metrics are currently unavailable for standard analysis.

재무 건전성

The company reported a trailing twelve-month revenue of $9.81M, yet it recorded a net income of -$719,217,024, revealing a catastrophic divergence between top-line activity and bottom-line profitability. This massive negative gap between revenue and net income indicates an extremely distorted cost structure where expenses, likely including significant impairment charges or one-time write-downs, far exceed all operating revenues. The EBITDA figure stands at -$24,719,000, further confirming that the business is generating negative operating cash flow before financing costs and taxes. Free cash flow is reported at -$1,212,590,720, which signifies a severe lack of financial flexibility and an inability to fund operations or capital expenditures from internal cash generation. Gross margin is 26.3%, suggesting that the direct cost of claims recovery services consumes roughly three-quarters of revenue, while the operating margin of -62501.5% and profit margin of 0.0% highlight extreme inefficiencies in overhead management or the recognition of massive non-recurring losses. Total cash on hand amounts to $1.82M, which is negligible when compared to total debt of $891.81M, creating a highly leveraged balance sheet where liabilities dwarf liquid assets. The debt-to-equity ratio is listed as N/A, but the sheer magnitude of debt against minimal cash suggests a precarious solvency position. The current ratio is 0.01, indicating that the company possesses only 1 cent of current assets for every dollar of current liabilities, which points to a critical shortage of short-term liquidity and a high risk of default. Return on Equity is -130968.7% and Return on Assets is -14.5%, metrics that reveal management is destroying shareholder value and utilizing assets inefficiently rather than generating returns.

밸류에이션 평가

Trailing P/E and forward P/E ratios are both listed as N/A due to the absence of positive earnings, rendering traditional earnings-based valuation multiples inapplicable for this asset. The price-to-book ratio is -0.00, a figure that technically indicates the market value is zero or negative relative to the company's book value, often seen in distressed situations where liabilities exceed assets. The price-to-sales ratio and EV/EBITDA are also N/A, suggesting that alternative valuation metrics relying on revenue multiples or enterprise value leverage are currently indeterminate or undefined for this specific reporting period. The 52-week high for the stock is $0.07, while the 52-week low is $0.00, meaning the current trading price sits at the absolute floor of its annual trading range and exhibits extreme price compression relative to its recent volatility history. The beta value is -2.81, a unique and anomalous metric that suggests the stock price moves inversely to the broader market with high intensity, implying that when the market rises, this stock tends to fall disproportionately, and vice versa. This negative beta and the proximity to the zero-dollar low indicate that the asset carries extreme idiosyncratic risk and behaves differently than standard equity instruments in the market.

Growth & Income

Revenue growth year-over-year is -94.6%, while earnings growth is N/A due to the company's significant losses, indicating that the business is contracting sharply rather than expanding its market share. Since earnings are negative and declining, the comparison between revenue and earnings growth rates is not applicable in a traditional sense, but the contraction in revenue suggests a shrinking operational base or loss of key contracts. The company does not pay a dividend, as the dividend yield and payout ratio are both listed as N/A, which is consistent with firms that are not profitable and must retain any available cash to service debt or cover operating deficits. Consequently, the company reinvests earnings—or rather, its limited cash reserves—into maintaining operations rather than distributing income to shareholders, a strategy forced upon it by its current financial distress. The overall growth and income profile is characterized by severe revenue contraction, negative profitability, and an absence of income distribution, presenting a challenging environment for capital preservation.